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We compared 581 Salmonella enterica serotype 
Schwarzengrund isolates from persons, food, and food 
animals in Denmark, Thailand, and the United States by 
antimicrobial drug susceptibility and pulsed-ﬁ  eld gel elec-
trophoresis (PFGE) typing. Resistance, including resistance 
to nalidixic acid, was frequent among isolates from persons 
and chickens in Thailand, persons in the United States, and 
food imported from Thailand to Denmark and the United 
States. A total of 183 PFGE patterns were observed, and 
136 (23.4%) isolates had the 3 most common patterns. 
Seven of 14 isolates from persons in Denmark had patterns 
found in persons and chicken meat in Thailand; 22 of 390 
human isolates from the United States had patterns found 
in Denmark and Thailand. This study suggests spread of 
multidrug-resistant  S. Schwarzengrund from chickens to 
persons in Thailand, and from imported Thai food products 
to persons in Denmark and the United States.
S
almonella enterica is a common cause of human gastro-
enteritis and bacteremia worldwide, and a wide variety 
of animals, particularly food animals, have been identiﬁ  ed 
as reservoirs for nontyphoidal Salmonella spp. (1–3). Hu-
man infections with nontyphoidal Salmonella are com-
monly caused by ingestion of food that has been contami-
nated by animal feces (3). Although >2,500 serovars of S. 
enterica have been identiﬁ  ed, most human infections are 
caused by a limited number of serovars. S. serovar Ty-
phimurium and serovar Enteritidis are the most common 
causes of human salmonellosis worldwide, although other 
serovars have been reported to be more prevalent in some 
regions (3–7). Shifts in prevalence of speciﬁ  c strain types 
and serovars can reﬂ  ect the inﬂ  uence of international travel 
and trade of animals and food products, and can therefore 
serve as useful epidemiologic markers.
We recently reported an increase in the prevalence of 
S. serovar Schwarzengrund in broiler chickens in Thailand 
and an increase in the proportion of human Salmonella 
infections caused by S. Schwarzengrund in Thailand (6), 
from 0% in 1992 to 2.4% in 2001. This serovar was also re-
cently reported as causing more illness in Denmark (www.
germ.dk) and the United States, where several isolates have 
shown multidrug resistance (8,9).
In recent years, an increase in antimicrobial drug re-
sistance, including resistance to nalidixic acid, among 
Salmonella spp. has been observed in many countries, 
particularly in Asia (10–17). Nalidixic acid–resistant and 
ciproﬂ  oxacin-resistant  S. Schwarzengrund has been re-
ported in Taiwan (18) and the United States (9), the US 
cases linked to patients previously hospitalized in the Phil-
ippines. The emergence of antimicrobial drug resistance 
is a matter of concern. Persons with infections caused by 
antimicrobial drug–resistant Salmonella spp., particularly 
nalidixic acid–resistant Salmonella spp., are more likely to 
die, are more likely to be hospitalized, and are hospitalized 
for longer periods than patients with infections caused by 
susceptible strains (18–20).
Antimicrobial drug susceptibility proﬁ  les and genetic 
strain typing methods are useful epidemiologic tools to de-
termine the sources of infections, including potential links 
between food animals and persons. Pulsed-ﬁ  eld gel elec-
trophoresis (PFGE) is highly discriminatory and useful in 
epidemiologic studies (21,22). To our knowledge, no mo-
lecular studies on S. Schwarzengrund have been previously 
described.
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This study was conducted to determine the clonality 
and molecular variation of S. Schwarzengrund from per-
sons, food products, and animals in Denmark, Thailand, 
and the United States. In addition, antimicrobial drug resis-
tance proﬁ  les were determined for some of the isolates. The 
implications of the ﬁ  ndings in relation to the global spread 
of new serovars and the potential international spread by 
imported food products are discussed.
Materials and Methods
Bacterial Isolates
A total of 581 S. Schwarzengrund isolates were includ-
ed, 73 from Denmark, 105 from Thailand, and 403 from 
the United States. All available isolates were selected from 
the strain collections at the Danish Institute for Food and 
Veterinary Research (n = 59) and Statens Serum Institut 
in Denmark (n = 14); the World Health Organization In-
ternational Salmonella and Shigella Centre in Thailand (n 
= 105); and the US Food and Drug Administration (n = 7) 
and Centers for Disease Control and Prevention (CDC) in 
the United States (n = 396) (Table). 
The 73 isolates from Denmark were isolated from 1995 
to 2004: 14 from ill persons, ≥2 of whom reported travel 
to Thailand in the 30 days before specimen collection; 22 
from pigs on farms; 20 from chicken meat; 9 from turkey 
meat; 4 from pork; and 4 from other food sources. Of the 
20 chicken meat products tested in Denmark, >13 were im-
ported, and 10 of these were known to be from Thailand. 
The origin of the remaining 7 chicken meat products was 
not known. The 105 isolates from Thailand were isolated 
from 1994 to 2003 and included 57 from ill persons at 17 
different medical facilities and 48 from chicken meat. The 
403 isolates from the United States were isolated from 
1998 to 2005: 390 from ill persons, 4 from turkey meat, 3 
from chicken meat, 2 from pigs on farms, 1 from a turkey 
on a farm, 1 from a squid roll imported from Taiwan, 1 
from a catﬁ  sh imported from Thailand, and 1 from a dehy-
drated whole chili imported from Thailand. Most isolates 
from Denmark and Thailand, but only a limited number of 
isolates from the United States, were available for suscep-
tibility testing.
Antimicrobial Drug Susceptibility
Of the 581 isolates obtained, 204 were tested for anti-
microbial drug susceptibility: 69 from Denmark, 90 from 
Thailand, and 45 from the United States. Susceptibility to 
antimicrobial agents was performed as MIC determinations 
by using a commercially prepared, dehydrated panel (Sensi-
titer; TREK Diagnostic Systems Ltd., East Grinstead, UK), 
according to the Clinical and Laboratory Standards Insti-
tute/National Committee for Clinical Laboratory Standards 
(23) for the following antimicrobial agents: ampicillin, 
ceftiofur, chloramphenicol, ciproﬂ  oxacin, gentamicin, na-
lidixic acid, streptomycin, sulfamethoxazole, and tetracy-
cline. Reduced susceptibility to ciproﬂ  oxacin was deﬁ  ned 
as MIC >0.125 mg/L and resistance as MIC >4 mg/L.
Table. Origin and occurrence of resistance among Salmonella enterica serovar Schwarzengrund isolates from humans, food, and food 
animals in Denmark, Thailand, and the United States 
No. isolates resistant to antimicrobial drugs*  
Country/source 
No. isolates tested/
total no. isolates  AMP CHL CIP GEN NAL STR SUL TET
Denmark
Humans 14/14 8 3 1 6 8 11 9 8
P i g s  o n  f a r m   2 2 / 2 2 0 2000422
P o r k 4 / 4 0 0000000
Chicken meat of 
unknown origin 
7 / 7 4 1045564
Imported chicken  13/13 11 0 0 11 11 12 13 13
Imported turkey  9/9 1 0 0 1 1 4 4 4
O t h e r s 0 / 4 – –––––––
Thailand
Humans† 46/57 30 13 10 27 42 45 41 35
Chicken meat  44/48 23 16 2 28 39 39 36 23
T u r k e y  m e a t   2 / 4 0 0000000
United States 
Humans 38/390 13 08 16 4 17 4 20 22
C h i c k e n  m e a t   0 / 3 – –––––––
Turkey on farm  0/1 – – – – – – – –
P i g s  o n  f a r m   2 / 2 0 0000011
Imported food  3/3 1 2 1 2 3 2 3 3
Total 204/581 91 45 30 83 126 126 135 115
*AMP, ampicillin; CHL, chloramphenicol; CIP, ciprofloxacin; GEN, gentamicin; NAL, nalidixic acid; STR, streptomycin; SUL, sulfamethoxazole; TET, 
tetracycline. 
†One human isolate from Thailand was resistant to ceftiofur. RESEARCH
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Pulsed-Field Gel Electrophoresis
All 581 isolates were analyzed for genetic relatedness 
by PFGE by using XbaI according to the CDC PulseNet 
protocol (24). Electrophoresis was performed with a CHEF-
DR III System (Bio-Rad Laboratories, Hercules, CA, USA) 
by using 1% SeaKem agarose in 0.5× Tris-borate-EDTA at 
180 V. Running conditions consisted of 1 phase from 2.2 to 
63.8 s for a run time of 22 h.
All isolates from Denmark and Thailand and 7 of 
the food isolates from the United States were typed at the 
Danish Institute for Food and Veterinary Research; the 
remaining isolates from the United States were typed by 
PulseNet-participating state and local health departments, 
with the PFGE patterns submitted to the PulseNet database. 
One representative of each PFGE type identiﬁ  ed in Den-
mark was sent to CDC for comparison with the PulseNet 
database. Comparison of the PFGE proﬁ  les was performed 




Among the 69 isolates from Denmark, nalidixic acid 
resistance was found in 8 (57%) of 14 human isolates, in-
cluding those from both patients with known recent travel 
to Thailand, and in 16 (80%) of 20 chicken isolates, in-
cluding all 10 isolates from chicken imported from Thai-
land. Nalidixic acid resistance was not found in pig, pork, 
or turkey meat isolates (Table). All nalidixic acid–resistant 
isolates from Denmark also displayed reduced susceptibil-
ity to ciproﬂ  oxacin. Nalidixic acid resistance was common 
among isolates from Thailand, including 42 (91%) of 46 
human isolates and 39 (89%) of 44 chicken meat isolates. 
All nalidixic acid–resistant isolates from Thailand also ex-
hibited reduced susceptibility to ciproﬂ  oxacin; 12 isolates 
(10 from persons and 2 from chickens) were resistant to 
ciproﬂ   oxacin. Ten of the ciproﬂ  oxacin-resistant  isolates 
from Thailand contained 2 single-base substitutions in the 
gyrA gene at codons 83 [(TCC (Ser) → TTC (Phe))] and 87 
[(GAC (Asp) → AAC (Asn))]. (Mutated bases are shown 
in boldface.)
Among the 45 isolates from the United States for 
which susceptibility results were available, nalidixic acid 
resistance was found in 17 (45%) of 38 human isolates and 
3 (43%) of 7 food and food animal isolates, including all 
3 isolates from imported food from Thailand and Taiwan. 
All nalidixic acid–resistant isolates from the United States 
also showed decreased susceptibility to ciproﬂ  oxacin; 16 
of the 17 nalidixic acid–resistant isolates from persons and 
the isolate from an imported dehydrated whole chili from 
Thailand were resistant to ciproﬂ  oxacin.
Pulsed-Field Gel Electrophoresis
A total of 180 unique PFGE patterns were observed 
among the 581 isolates, with 136 (23%) isolates having the 
3 most common patterns (online Appendix Figure, avail-
able from www.cdc.gov/EID/content/13/5/726-appG.htm). 
The most common pattern (58 isolates, JM6X01.0001) rep-
resented only human isolates from the United States; 5 of 
these isolates were susceptibility tested, and all were resis-
tant to sulfamethoxazole and tetracycline and susceptible 
to all other antimicrobial agents tested. The second most 
common pattern (44 isolates, JM6X01.0091) included iso-
lates from persons in Denmark, chicken meat imported 
from Thailand to Denmark, and persons and chickens in 
Thailand; all 44 isolates were susceptibility tested, and 42 
(95%) were nalidixic acid resistant. The third most com-
mon pattern (34 isolates, JM6X01.0015) included isolates 
from persons and chicken meat in Denmark, persons and 
chicken meat in Thailand, persons in the United States, and 
catﬁ  sh imported from Thailand to the United States; 20 of 
these isolates were tested for susceptibility, and 15 (75%) 
were nalidixic acid resistant.
Two additional patterns are noteworthy. One pattern 
(18 isolates, JM6X01.0059) included 1 isolate from a per-
son in Denmark, 5 isolates from chicken and 9 isolates 
from persons in Thailand, 2 isolates from persons in the 
United States, and the isolate from the dehydrated whole 
chili imported from Thailand to the United States. Of the 
9 isolates that underwent susceptibility testing, 7 (78%) 
were ciproﬂ  oxacin-resistant. Another pattern (14 isolates, 
JM6X01.004) included only human isolates from the Unit-
ed States; 10 of these isolates were susceptibility tested, 
and all were ciproﬂ   oxacin-resistant. This is the pattern 
from the previously described outbreak of ciproﬂ  oxacin-
resistant S. Schwarzengrund infections in medical facilities 
in Oregon (9).
Twenty-six different PFGE types were found among 
the 73 isolates from Denmark (online Appendix Figure). Of 
these, 11 were found among 14 human isolates, 10 among 
the 26 isolates from pigs and pork, 7 among the 19 chicken 
meat isolates, and 4 among the 9 turkey meat isolates. Sev-
en (50%) human isolates belonged to types that were also 
found in food, including 6 PFGE types found in chickens. 
Forty-three different PFGE types were found among the 
105 isolates from Thailand; 25 of these were found among 
the 57 human isolates and 25 among the 48 chicken meat 
isolates. Thirty-ﬁ  ve (61%) of the human isolates and 30 
(63%) of the chicken isolates belonged to PFGE types that 
were found in both sources.
Four of the 6 PFGE types, involving 7 of the 14 isolates 
found among persons and chickens in Denmark, were also 
observed among persons and chicken meat in Thailand. Both 
ill persons in Denmark who reported travel to Thailand in the 
30 days before specimen collection were infected with 1 of Spread of Resistant Salmonella Schwarzengrund
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the PFGE types common in Denmark and Thailand. These 
4 PFGE types included the most common type among per-
sons and chickens in Denmark and the 2 most common types 
among persons and chickens in Thailand.
Among the 403 isolates from the United States, 121 
different PFGE types were found; 116 of these were found 
among the 390 human isolates and 12 among the 13 food 
and food animal isolates. Seven PFGE types were found in 
both persons and food; 73 (19%) of the human isolates and 
8 (62%) of the food isolates belonged to types found in per-
sons and food. All 8 food isolates with types also found in 
persons were found in foods imported to the United States, 
including food imported from Thailand. Twenty-two (6%) 
of the 390 human isolates from the United States matched 
PFGE patterns found in persons and chickens in Denmark 
or Thailand. Of the 19 isolates from persons in Denmark 
and the United States that belonged to PFGE types found 
in both countries and Thailand, 4 were tested for resistance 
and 3 (75%) of these were multidrug resistant.
Discussion
Foodborne diseases caused by nontyphoidal Salmonel-
la spp. represent an important public health problem world-
wide. In Denmark alone, the costs related to foodborne cas-
es of salmonellosis were estimated to be US $10.4 million 
to $25.5 million in 2001 (25). In the United States nonty-
phoidal Salmonella spp. are responsible for an estimated 
>1.4 million illnesses, almost 16,000 hospitalizations, and 
>500 deaths every year (26) at an estimated annual cost of 
up to $2.3 billion. (27).
Historically,  Salmonella serotypes Enteritidis and 
Typhimurium have been the most important causes of 
nontyphoidal salmonellosis. S. Schwarzengrund is a less 
common cause of human salmonellosis worldwide. In re-
cent years, however, the relative incidence of this serovar 
seems to have increased (6,8). It now ranks among the 20 
most frequently identiﬁ  ed Salmonella serovars in several 
countries, including Slovakia, New Zealand, Venezuela, 
and Thailand; is among the 40 most frequently identiﬁ  ed 
serovars in Denmark and the United States; and was the 
ﬁ  fth most common serovar isolated from retail meat in the 
United States in 2004, associated exclusively with poultry 
products. Other studies also suggest that poultry could be 
the most common reservoir (6,28,29).
This study showed a high frequency of antimicrobial 
drug resistance, including an unusually high prevalence 
of nalidixic acid resistance, among S. Schwarzengrund 
isolates from chickens in Denmark, persons and chickens 
in Thailand, and food products imported into the United 
States. In contrast, the frequency of resistant isolates from 
pigs and turkey meat in Denmark was low. The prevalence 
of resistance among isolates from persons in Denmark 
was intermediate compared with the high level in persons 
and chickens in Thailand and the low level in Danish food 
animals. Along with the PFGE data, these resistance data 
support a hypothetical transmission of S. Schwarzengrund 
from chickens to persons in Thailand, and transmission 
from chickens, pigs, and turkeys to persons in Denmark.
Ciproﬂ  oxacin resistance was detected in 29 (24%) of 
123 nalidixic acid–resistant S.  Schwarzengrund isolates. 
Fluoroquinolone (ciproﬂ  oxacin)  resistance  among  Sal-
monella spp. has recently emerged in several countries 
(30–32). Ten ciproﬂ  oxacin-resistant isolates tested in this 
study contained double mutations in gyrA at codons 83 (Ser 
→ Phe) and 87 (Asp → Asn). These positions, located in 
the quinolone resistance–determining region of gyrA, are 
commonly reported among numerous bacterial species, 
including Salmonella isolates with a high-level of cipro-
ﬂ  oxacin resistance (30–32). A ciproﬂ  oxacin-resistant strain 
of S. Schwarzengrund recently caused a nosocomial out-
break involving 2 nursing homes and 1 hospital in Oregon 
(9). The index patient in the Oregon outbreak was initially 
hospitalized in the Philippines. In many countries, includ-
ing Denmark, ﬂ  uoroquinolones are the drugs of choice for 
treating complicated gastrointestinal infections. Thus, re-
sistance to this group of antimicrobial agents is especially 
critical, both for management of salmonellosis and because 
of the association of resistance with increased illness and 
death (19,20).
To our knowledge, this is the ﬁ  rst study of the mo-
lecular epidemiology of S. Schwarzengrund. The study 
demonstrated a substantial diversity in PFGE patterns of 
this serotype with the presence of several common interna-
tional clones. The PFGE types of isolates from persons and 
chicken meat in Thailand formed overlapping populations, 
with more than half of the isolates from both sources be-
longing to shared types. This supports the involvement of 
chicken meat as a reservoir for human S. Schwarzengrund 
infections in Thailand. 
The epidemiology of S. Schwarzengrund infections in 
Denmark is complicated. Although some PFGE types were 
only found among isolates from pigs, several PFGE types 
were shared among isolates from persons and pigs; persons, 
chicken meat, and turkey meat; and persons and chicken 
meat. This suggests that chicken meat, pork, and turkey 
meat are sources of S. Schwarzengrund infections for per-
sons in Denmark. Because modern trade and distribution of 
food products makes it difﬁ  cult to determine the country of 
origin of meat samples sold retail in Denmark, the sources 
of the chicken meat, pork, and turkey meat included in this 
study are not completely known. However, Denmark has 
been importing an increasing amount of chicken meat, and 
much of this imported chicken is from Thailand. In addi-
tion, S. Schwarzengrund has, to our knowledge, not been 
detected in the Danish production of chicken. In this study, 
>13 of the 20 chicken meat products tested in Denmark RESEARCH
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were imported, and 10 of these were from Thailand. These 
data, with the identiﬁ  cation of identical PFGE types from 
persons and chickens in both Denmark and Thailand, sup-
port the possibility that some persons in Denmark acquired 
S. Schwarzengrund from imported chicken meat from 
Thailand. Another less frequent means of acquiring the in-
fections is travel by persons from Denmark to Thailand; >2 
of the 14 case-patients in Denmark had recently returned 
from travel to Thailand before they became ill.
A limited number of isolates from food and food ani-
mals in the United States were included in this study. The 
prevalence of S. Schwarzengrund in retail meat was low 
in 2003, with only 3 isolates recovered. In addition, PFGE 
data on isolates from food animals were not available for 
comparison in this study. The study would have beneﬁ  ted 
from additional isolates, especially from food and food 
animals in the United States. Nevertheless, a high propor-
tion of these available isolates from food and food animals 
shared PFGE patterns with human isolates. In addition, 
several patterns found among human isolates in the United 
States were also present among human isolates in Denmark 
and Thailand, which suggests an international spread of 
these clones. Speciﬁ  cally, 1 PFGE type that was frequently 
ciproﬂ  oxacin resistant was found in a person in Denmark, 
in persons and chicken meat in Thailand, and in persons 
and the dehydrated whole chili imported from Thailand to 
the United States. Another PFGE type that was nalidixic 
acid–resistant was found in persons and chicken meat in 
Denmark, persons in the United States, and in catﬁ  sh im-
ported from Thailand to the United States.
In our study and other studies, Salmonella isolates 
from imported food in Denmark had a higher frequency of 
resistance than was found in domestically produced meats 
(33). A study from the United States also reported a high 
frequency of antimicrobial drug resistance among Salmo-
nella isolates from imported food (34). Food is an impor-
tant vehicle for the national and international dissemination 
of Salmonella spp. and antimicrobial drug resistance genes 
from food animals to persons (35–38).
This study supports the conclusion that multidrug-re-
sistant, including nalidixic acid–resistant, S. Schwarzen-
grund was likely disseminated internationally by chicken 
products from Thailand. Because antimicrobial drug resis-
tance among Salmonella isolates from food animals com-
monly reﬂ  ects antimicrobial drug use in food animals, ef-
forts are needed to ensure appropriate use of antimicrobial 
agents in food animals and to improve food safety to reduce 
dissemination of Salmonella spp. worldwide.
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